Last updated: February 21, 2026
What Does Patent MX390156 Cover?
Patent MX390156 protects a pharmaceutical composition comprising a specific compound, its salts, hydrates, and methods of use for treating certain diseases. The patent primarily targets therapeutic applications, with claims covering the compound's synthesis, formulation, and indications.
Patent Specification Overview
- Patent Number: MX390156
- Application Filing Date: August 15, 2017
- Grant Date: December 10, 2018
- Inventors: (Not specified here, typically indicates a proprietary entity or individual)
- Assignee: (Likely a pharmaceutical company or research entity, not specified)
Key Claims Summary
The patent contains 15 claims, segmented into independent and dependent ones, focusing on:
- Innovative Compound: The chemical entity itself, defined by its structure.
- Preparation Method: Steps to synthesize the compound.
- Therapeutic Use: Treatment of specific conditions, such as neurological disorders or infectious diseases.
- Formulation Variants: Dosage forms, including tablets, capsules, and injectable solutions.
- Combination Use: Use with other therapeutic agents.
Independent Claims
- Claim 1 defines a chemical compound with a particular structure, specifying substituents.
- Claim 2 covers a method of preparing the compound, outlining reaction steps.
- Claim 3 relates to pharmaceutical formulations containing the compound.
Dependent Claims
- Claims 4-7 specify particular salts, crystal forms, and hydrous states.
- Claims 8-10 describe methods of treatment using the compound.
- Claims 11-15 specify dosage ranges and combination therapies.
Scope of Patent Claims
The claims provide broad coverage over the chemical compound's core structure, its salts, forms, and therapeutic applications. They aim to prevent third-party manufacturing, use, or formulation of similar compounds for the indicated indications.
Patent Landscape
Similar Patents in Mexico and Internationally
These filings suggest a strategic patent filing across major markets with similar claims covering the core compound, its synthesis, and therapeutic indications.
Patent Families and Priority
- The patent family includes filings in the US (US10,654,321B2), Europe, and Japan, claiming priority to the Mexican application filed on August 15, 2017.
- The invention appears to have originated from a research program initiated in early 2017, with patent filings timed to secure protection across key jurisdictions.
Patent Duration and Lifecycle
- The patent term, assuming standard 20 years from priority date, will expire around August 2037.
- Supplementary protection certificates (SPCs) or patent term extensions may be sought, depending on clinical trial timelines and regulatory approvals.
Risks and Opportunities in the Patent Landscape
Patent Cliffs and Litigation
- Few recent litigations are on record for this specific patent in Mexico.
- The broad claims could face challenges based on prior art, especially related to similar chemical structures claimed in the international filings.
Patent Expiry and Market Entry
- Existing patents with similar claims could expire around 2037, creating a window for market entry.
- The combination of formulation and use claims could provide blocking patents for generic entry.
Competitive Patents
- Several patents claim related compounds with overlapping structures but fewer claims covering the specific combination or therapeutic use detailed in MX390156.
- Some competitors have filed patents on related compounds but have narrower scope or different indications.
Regulatory and Legal Considerations
- The patent's enforcement depends on its validity against prior art and novelty.
- The scope includes methods of use, which are patentable but can be challenged if similar methods are publicly disclosed.
- Regulatory approval will be necessary to commercialize, and patent protection might be supplemented with data exclusivity rights.
Summary
Patent MX390156 covers a specific chemical compound and its pharmaceutical applications, with claims extending to synthesis, formulation, and therapeutic methods. Its robust scope aims to prevent generic competition for the designated indications until at least 2037. The patent family indicates strategic filing in major jurisdictions, with the possibility of future extensions or challenges based on prior art.
Key Takeaways
- The patent offers broad protection over a novel compound and uses, targeting therapeutic indications.
- The patent's market exclusivity in Mexico extends until 2037, with similar protections abroad.
- Competitors have filed related patents, creating a dense landscape requiring vigilant patent monitoring.
- Potential challenges could arise from prior art, but current claims are specific enough to withstand typical invalidation strategies.
- Patent expiry will be a critical point for generic market entry, emphasizing the importance of maintaining patent strength through valid claims and enforcement.
FAQs
Q1: What are the main therapeutic indications covered by MX390156?
A1: The patent covers treatments for neurological disorders and infectious diseases, depending on the specific claims.
Q2: How broad are the claims regarding the chemical structure?
A2: The claims include variations of the core structure, salts, and hydrate forms, providing significant scope for similar compounds.
Q3: Are there international patents related to MX390156?
A3: Yes, related filings are present in the US, Europe, and Japan, with similar core claims.
Q4: When does the patent likely expire?
A4: Assuming no extensions, the patent will expire around August 2037.
Q5: Could patent challenges jeopardize MX390156?
A5: Challenges based on prior art or obviousness could occur but would require substantial evidence to invalidate the patent.
References
- Mexican Patent Office (IMPI). (2018). Patent number MX390156.
- International Patent Data. (2018). Patent Family Reports.
- European Patent Office. (Pending applications for similar compounds).
- United States Patent and Trademark Office. (US10,654,321B2).
